Federated Hermes, Inc. Alpine Immune Sciences, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$17.75 - $41.6 $2.46 Million - $5.77 Million	138,616 Added 37976.99%	138,981 $5.51 Million
Q4 2023 Jan 31, 2024	BUY	$8.54 - $20.22 $3,117 - $7,380	365 New	365 $6,000
Q1 2021 May 13, 2021	SELL	$10.02 - $13.92 $2,364 - $3,285	-236 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$7.42 - $15.96 $1,528 - $3,287	206 Added 686.67%	236 $3,000
Q3 2020 Nov 12, 2020	BUY	$7.15 - $11.5 $214 - $345	30 New	30 $1,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.